Saving changes...

Done

Error

Genomic Abnormalities and core organ function deficits: Effects on Immune System, Vitamin D and A function

Genomic Abnormalities and core organ function deficits: Effects on Immune System, Vitamin D and A function

Genomic Abnormalities and core organ function deficits: Effects on Immune System, Vitamin D and A function

Dr. Paul Anderson, ND
Dr. Paul Anderson, ND
on behalf of Washington State Pharmacy Association

$49.00 $ 49.00 $ 49.00

$49.00 $ 49.00 $ 49.00

$ 49.00 $ 49.00 $ 49.00
$ 49.00 $ 49.00 $ 49.00
Normal Price: $49.00 $49.00

Review:

Launch date: 29 Sep 2015

Expiry Date: 28 Sep 2018

Last updated: 13 Mar 2017

Reference: 161320

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

As we can now locate and assess SNP defects that change the genome and epigenetics we also can assess and treat these areas for both preventive and disease specific outcomes. Do you ever wonder why some patients get “every infection” and their partner doesn’t? Why some take a dose of a drug and have horrible side effects and some do not? Why some families have thyroiditis or maculopathy “running in them” and others don’t? It is all of course multifactorial but it is also the interplay between the genome and epigenome. In this presentation Dr. Anderson will point out the signs, symptoms, family history and SNP’s to look into. Where early detection is critical, and how to clinically manage these areas.


ACPE UAN # 0130-9999-15-088-H04-P | Activity Type: Knowledge | Initial Release Date: 09-28-2015 | Planned Expiration Date: 09-28-2018

Objectives

Objectives
Define the SNP’s commonly associated with mitochondrial function.
Relate which areas modulate retinoid conversion and affect eye health.
Describe clinically how to implement appropriate retinoid therapy in BCMO SNP positive patients.
Dr. Paul Anderson, ND

Author Information Play Video Bio

Dr. Paul Anderson, ND
on behalf of Washington State Pharmacy Association

Dr. Paul Anderson is medical director of Anderson Medical Specialty Associates, a clinic focusing on the care of patients with cancer and chronic diseases. Former positions include professor of Pharmacology and Clinical Medicine at Bastyr University and Chief of IV Services for Bastyr Oncology Research Center. he is a graduate of NCNM and began instructing classes at naturopathic medical schools in the early 1990s. He continues to hold board review classes and CME courses for most of the US and Canadian ND programs, including BU, NCNM, Boucher Institute, UB, SCNM and CCNM. He also is a founding board member of the Academy of Parenteral Therapies specialty group and an instructor and author for the IIVNTP IV Therapy training group.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.50 Hours -
    Reference: 0130-9999-15-088-H04-P

Faculty and Disclosures

undefined

Details

You must own the training to change the number

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error